secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenon Medical, Inc. (TNON)
CIK:        0001560293
Form:       8-K
Filed at:   2025-09-23T23:59:59+00:00
Accession:  0001213900-25-090627
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tenon Medical shareholders approve warrant exercisability and equity plan increase at 2025 annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected: Ferrari, Foster, Ginn, Hochschuler, Howard, Jacques, Weigle each received >2.48M votes for.
- Approved exercisability of Series C-1 (up to 2,445,700 shares) and C-2 (up to 1,222,850 shares) warrants at $1.25/share; 2,517,314 for, 120,940 against.
- 2022 Equity Incentive Plan amendments approved: share reserve increased from 189,870 to 1,328,365 shares; evergreen provision modified to up to 4% outstanding annually.
- Ratified Haskell & White LLP as independent auditor for FY2025 with 4,488,067 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560293/000121390025090627/0001213900-25-090627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560293/000121390025090627/ea0258406-8k_tenon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-090627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer